blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1268433

EP1268433 - CYCLIC LACTAMS AS INHIBITORS OF A-BETA-PROTEIN PRODUCTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.03.2005
Database last updated on 13.07.2024
Most recent event   Tooltip08.08.2008Change - applicantpublished on 10.09.2008  [2008/37]
Applicant(s)For all designated states
Bristol-Myers Squibb Pharma Company
P.O. Box 4000
Princeton NJ 08543-4000 / US
[2008/37]
Former [2003/01]For all designated states
Bristol-Myers Squibb Pharma Company
PO Box 4000
Princeton, New Jersey 08443-4000 / US
Inventor(s)01 / OLSON, Richard, E.
7 Pelham Road
Wilmington, DE 19803 / US
02 / YANG, Michael, G.
15 South Hampshire Court
Wilmington, DE 19807 / US
 [2003/01]
Representative(s)Howard, Paul Nicholas, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2003/01]Howard, Paul Nicholas, et al
Carpmaels & Ransford 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date01926560.203.04.2001
[2003/01]
WO2001US10667
Priority number, dateUS20000194503P03.04.2000         Original published format: US 194503 P
[2003/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0174783
Date:11.10.2001
Language:EN
[2001/41]
Type: A1 Application with search report 
No.:EP1268433
Date:02.01.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 11.10.2001 takes the place of the publication of the European patent application.
[2003/01]
Search report(s)International search report - published on:EP11.10.2001
ClassificationIPC:C07D223/18, C07D243/24, C07D401/12, C07D223/12, C07D403/12, C07D223/16, C07D243/14, C07D401/06, A61K31/55, A61K31/551, A61K31/5513, A61P25/28, C07K5/06, C07K5/08, A61K38/00
[2003/01]
CPC:
C07D223/16 (EP,US); A61K31/4015 (EP,US); A61K31/445 (EP,US);
A61K31/55 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P43/00 (EP); C07D223/10 (EP,US); C07D223/12 (EP,US);
C07D223/18 (EP,US); C07D243/14 (EP,US); C07D243/24 (EP,US);
C07D401/06 (EP,US); C07D401/12 (EP,US); C07D403/12 (EP,US);
C07K5/0205 (EP,US); C07K5/06078 (EP,US); C07K5/06139 (EP,US);
C07K5/06191 (EP,US); C07K5/0812 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/01]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ZYKLISCHE LACTAME ALS A-BETA-PROTEINPRODUKTIONSINHIBITOREN[2003/01]
English:CYCLIC LACTAMS AS INHIBITORS OF A-BETA-PROTEIN PRODUCTION[2003/01]
French:LACTAMES CYCLIQUES UTILISES COMME INHIBITEURS DE LA PRODUCTION DE LA PROTEINE BETA-AMYLOIDE[2003/01]
Entry into regional phase05.09.2002National basic fee paid 
05.09.2002Designation fee(s) paid 
05.09.2002Examination fee paid 
Examination procedure26.10.2001Request for preliminary examination filed
International Preliminary Examining Authority: US
05.09.2002Amendment by applicant (claims and/or description)
05.09.2002Examination requested  [2003/01]
02.04.2004Despatch of a communication from the examining division (Time limit: M06)
13.10.2004Application deemed to be withdrawn, date of legal effect  [2005/16]
16.11.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/16]
Fees paidRenewal fee
05.09.2002Renewal fee patent year 03
15.04.2004Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4897489  (YOSHIOKA KOUICHI [JP], et al) [X] 1 * examples 46A,46B *;
 [XA]WO9216524  (MERCK & CO INC [US]) [X] 1-4 * example 19, step A * * page 62, line 14; example 29 * [A] 1,21;
 [X]US5378844  (BRUFANI MARIO [IT], et al) [X] 1 * column 5, line 48 - line 49 *;
 [X]WO9828268  (ATHENA NEUROSCIENCES INC [US], et al) [X] 1,21 * examples 7C-36,7C-224,7C-230,7C-236,7C-242 * * claim 2 *;
 [X]WO9966934  (ELAN PHARM INC [US], et al) [X] 1,21 * page 25; claim 41 *;
 [A]WO9967221  (ELAN PHARM INC [US], et al) [A] 1,21* claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.